Related Experiment Video
Updated: Jun 7, 2026

In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila
Published on: November 27, 2016
Living or dying by RNA processing: caspase expression in NSCLC
Ganesh Shankarling1, Kristen W Lynch
1Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Abstract:
Protein expression in humans is controlled by numerous RNA processing steps that occur between transcription of a gene and translation of protein. However, the importance of such regulatory steps to human diseases, especially cancer, is just now coming to light. Changes in the alternative splicing or stability of mRNA transcribed from genes involved in cell-cycle control, cell proliferation, and apoptosis has been linked to tumor formation and progression. Nevertheless, in the majority of these cases, the identity of the regulators that control the expression of such cancer-related genes is poorly understood. In this issue of the JCI, Goehe et al. demonstrate that heterogeneous nuclear ribonuclear protein family member L (hnRNP L), a member of the hnRNP family of RNA processing factors, is specifically phosphorylated in non-small cell lung cancer (NSCLC). The phosphorylated hnRNP L, in turn, promotes expression of the antiapoptotic form of caspase-9, thereby contributing to tumorigenesis.
Insights
Researchers found that a protein called heterogeneous nuclear ribonuclear protein L (hnRNP L) is altered in non-small cell lung cancer (NSCLC). This altered hnRNP L promotes cancer cell survival by affecting a protein that prevents cell death.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Processing
Background:
- RNA processing steps critically regulate human gene expression, influencing disease pathogenesis.
- Aberrant alternative splicing and mRNA stability of cancer-related genes are implicated in tumor formation and progression.
- The specific regulators controlling these altered gene expressions in cancer remain largely unidentified.
Discussion:
- Goehe et al. identify heterogeneous nuclear ribonuclear protein L (hnRNP L) as a key player in non-small cell lung cancer (NSCLC).
- hnRNP L undergoes specific phosphorylation in NSCLC, distinguishing it from normal cells.
- This modification links hnRNP L to the regulation of apoptosis-related genes.
Key Insights:
- Phosphorylated hnRNP L directly enhances the expression of the antiapoptotic form of caspase-9.
- This mechanism contributes to the uncontrolled cell proliferation and survival characteristic of NSCLC.
- The study elucidates a novel regulatory pathway in lung tumorigenesis.
Outlook:
- Further investigation into hnRNP L phosphorylation could reveal new therapeutic targets for NSCLC.
- Understanding hnRNP L's role may provide insights into other cancers driven by RNA processing alterations.
- This work highlights the importance of RNA-binding proteins in cancer development and progression.
Related Concept Videos
Caspases
RNA Splicing
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
What is Gene Expression?

